Actively Recruiting
Evaluating a Tele-diabetes Remote Monitoring System Using WhatsApp Alerts to Improve Blood Sugar Control and Quality of Life in Children and Youth With Type 1 Diabetes
Led by Sheba Medical Center · Updated on 2026-09-18
100
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a tele-diabetes remote monitoring system designed to help children and youth with Type 1 Diabetes T1DM. This system uses WhatsApp-based alerts to notify participants about glucose trends such as hypoglycemia and hyperglycemia. The study aims to assess whether this approach can improve blood sugar control, increase treatment adherence, enhance quality of life, and reduce emergency room visits, hospitalizations, and healthcare costs. Participants are randomly assigned to receive either the tele-diabetes system with automated WhatsApp alerts or continue with standard care. The tele-diabetes system includes a smart algorithm that monitors glucose in real-time and sends alerts when concerning patterns are detected. If multiple alerts occur, the medical team contacts participants through dietitian guidance, virtual physician consultation, or in-clinic visits for detailed evaluation and treatment adjustments. During the study, participants will be monitored at baseline and monthly for three months for glycemic control, treatment adherence, emergency visits due to diabetic ketoacidosis or hypoglycemia, hospitalizations, and satisfaction. The medical team supports participants through follow-ups between routine clinic visits, using both the alert system and clinical assessments to track outcomes and manage care.
CONDITIONS
Brief Title
Feasibility and Effectiveness of Tele-diabetes Remote System on Glycemic Control and Quality of Life of Children and Youth With Type 1 Diabetes
Research Team
N
Noah Gruber, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here